Pseudomonas aeruginosa Adaptation to Lungs of Cystic Fibrosis Patients Leads to Lowered Resistance to Phage and Protist Enemies

被引:32
|
作者
Friman, Ville-Petri [1 ,2 ]
Ghoul, Melanie [1 ]
Molin, Soren [3 ]
Johansen, Helle Krogh [4 ]
Buckling, Angus [2 ]
机构
[1] Univ Oxford, Dept Zool, Oxford OX1 3PS, England
[2] Univ Exeter, Penryn, England
[3] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark
[4] Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark
来源
PLOS ONE | 2013年 / 8卷 / 09期
基金
欧洲研究理事会; 英国生物技术与生命科学研究理事会; 英国惠康基金;
关键词
EVOLUTION; VIRULENCE; BACTERIA; HOST; PREDATION; DYNAMICS; COEVOLUTION; MULTIPLE; SURVIVAL; PROTOZOA;
D O I
10.1371/journal.pone.0075380
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pathogenic life styles can lead to highly specialized interactions with host species, potentially resulting in fitness trade-offs in other ecological contexts. Here we studied how adaptation of the environmentally transmitted bacterial pathogen, Pseudomonas aeruginosa, to cystic fibrosis (CF) patients affects its survival in the presence of natural phage (14/1, Phi KZ, PNM and PT7) and protist (Tetrahymena thermophila and Acanthamoebae polyphaga) enemies. We found that most of the bacteria isolated from relatively recently intermittently colonised patients (1-25 months), were innately phage-resistant and highly toxic for protists. In contrast, bacteria isolated from long time chronically infected patients (2-23 years), were less efficient in both resisting phages and killing protists. Moreover, chronic isolates showed reduced killing of wax moth larvae (Galleria mellonella) probably due to weaker in vitro growth and protease expression. These results suggest that P. aeruginosa long-term adaptation to CF-lungs could trade off with its survival in aquatic environmental reservoirs in the presence of microbial enemies, while lowered virulence could reduce pathogen opportunities to infect insect vectors; factors that are both likely to result in poorer environmental transmission. From an applied perspective, phage therapy could be useful against chronic P. aeruginosa lung infections that are often characterized by multidrug resistance: chronic isolates were least resistant to phages and their poor growth will likely slow down the emergence of beneficial resistance mutations.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis
    Elio Rossi
    Ruggero La Rosa
    Jennifer A. Bartell
    Rasmus L. Marvig
    Janus A. J. Haagensen
    Lea M. Sommer
    Søren Molin
    Helle Krogh Johansen
    Nature Reviews Microbiology, 2021, 19 : 331 - 342
  • [2] Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis
    Rossi, Elio
    La Rosa, Ruggero
    Bartell, Jennifer A.
    Marvig, Rasmus L.
    Haagensen, Janus A. J.
    Sommer, Lea M.
    Molin, Soren
    Johansen, Helle Krogh
    NATURE REVIEWS MICROBIOLOGY, 2021, 19 (05) : 331 - 342
  • [3] Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis
    Lamont, Iain L.
    Konings, Anna F.
    Reid, David W.
    BIOMETALS, 2009, 22 (01) : 53 - 60
  • [4] Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis
    Iain L. Lamont
    Anna F. Konings
    David W. Reid
    BioMetals, 2009, 22 : 53 - 60
  • [5] Microevolution of Pseudomonas aeruginosa in cystic fibrosis lungs
    Nina Cramer
    Jens Klockgether
    Colin F Davenport
    Burkhard Tümmler
    Molecular and Cellular Pediatrics, 1 (Suppl 1)
  • [6] MICROEVOLUTION OF PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS LUNGS
    Cramer, N.
    Klockgether, J.
    Davenport, C. F.
    Tuemmler, B.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 324 - 324
  • [7] MICROEVOLUTION OF PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS LUNGS
    Klockgether, J.
    Cramer, N.
    Fischer, S.
    Dorda, M.
    Wiehlmann, L.
    Tummler, B.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S337 - S337
  • [8] Clinical implications of Pseudomonas aeruginosa location in the lungs of patients with cystic fibrosis
    Moore, J. E.
    Mastoridis, P.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (03) : 259 - 267
  • [9] Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
    Smith, Eric E.
    Buckley, Danielle G.
    Wu, Zaining
    Saenphimmachak, Channakhone
    Hoffman, Lucas R.
    D'Argenio, David A.
    Miller, Samuel I.
    Ramsey, Bonnie W.
    Speert, David P.
    Moskowitz, Samuel M.
    Burns, Jane L.
    Kaul, Rajinder
    Olson, Maynard V.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (22) : 8487 - 8492
  • [10] Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients
    Ballestero, S
    FernandezRodriguez, A
    Villaverde, R
    Escobar, H
    PerezDiaz, JC
    Baquero, F
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (01) : 39 - 45